Clinical, biological, and prognostic implications of SF3B1 co-occurrence mutations in very low/low- and intermediate-risk MDS patients

Prognostic interaction between bone marrow morphology and SF3B1 and ASXL1 mutations in myelodysplastic syndromes with ring sideroblasts

(2018) Abhishek A. Mangaonkar et al.   Blood Cancer Journal

Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms

(2018) Guillermo Montalban-Bravo et al.   Oncotarget

New proposals of the WHO working group (2016) for the diagnosis of myelodysplastic syndromes (MDS): Characteristics of refined MDS types

(2017) Corinna Strupp et al.   LEUKEMIA RESEARCH

A two-step approach for sequencing spliceosome-related genes as a complementary diagnostic assay in MDS patients with ringed sideroblasts

(2017) Kamila Janusz et al.   LEUKEMIA RESEARCH

Prognostic impact of gene mutations in myelodysplastic syndromes with ring sideroblasts

(2017) Iván Martín et al.   Blood Cancer Journal

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

(2016) D. A. Arber et al.   BLOOD

The Impact of Somatic and Germline Mutations in Myelodysplastic Syndromes and Related Disorders

(2016) Rafael Bejar et al.   Journal of the National Comprehensive Cancer Network

Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

(2016) Peter L. Greenberg et al.   Journal of the National Comprehensive Cancer Network

Negative impact on clinical outcome of the mutational co-occurrence of SF3B1 and DNMT3A in refractory anemia with ring sideroblasts (RARS)

(2016) Iván Martín et al.   LEUKEMIA & LYMPHOMA

Mutations of myelodysplastic syndromes (MDS): An update

(2016) Bani Bandana Ganguly et al.   MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH

Myelodysplastic syndromes: Contemporary review and how we treat

(2015) Naseema Gangat et al.   AMERICAN JOURNAL OF HEMATOLOGY

SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts

(2015) L. Malcovati et al.   BLOOD

Recent advances in myelodysplastic syndromes: Molecular pathogenesis and its implications for targeted therapies

(2015) Hironori Harada et al.   CANCER SCIENCE

RECENT ADVANCES IN THE 5Q- SYNDROME

(2015) Andrea Pellagatti et al.   Mediterranean Journal of Hematology and Infectious Diseases

Somatic mutations and epigenetic abnormalities in myelodysplastic syndromes

(2014) Raphael Itzykson et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence

(2014) Giulio Genovese et al.   NEW ENGLAND JOURNAL OF MEDICINE

Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes

(2014) Siddhartha Jaiswal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical and biological implications of driver mutations in myelodysplastic syndromes

(2013) E. Papaemmanuil et al.   BLOOD

Role of DNMT3A, TET2, and IDH1/2 mutations in pre-leukemic stem cells in acute myeloid leukemia

(2013) Steven M. Chan et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Landscape of genetic lesions in 944 patients with myelodysplastic syndromes

(2013) T Haferlach et al.   LEUKEMIA

Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes

(2012) F. Thol et al.   BLOOD

Revised International Prognostic Scoring System for Myelodysplastic Syndromes

(2012) P. L. Greenberg et al.   BLOOD

New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge

(2012) Julie Schanz et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical importance of SF3B1 mutations in Chinese with myelodysplastic syndromes with ring sideroblasts

(2012) Rui Cui et al.   LEUKEMIA RESEARCH

SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value

(2011) M. M. Patnaik et al.   BLOOD

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

(2011) L. Malcovati et al.   BLOOD

Frequent pathway mutations of splicing machinery in myelodysplasia

(2011) Kenichi Yoshida et al.   NATURE

SomaticSF3B1Mutation in Myelodysplasia with Ring Sideroblasts

(2011) E. Papaemmanuil et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical Effect of Point Mutations in Myelodysplastic Syndromes

(2011) Rafael Bejar et al.   NEW ENGLAND JOURNAL OF MEDICINE

Advances in the 5q- syndrome

(2010) J. Boultwood et al.   BLOOD

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

(2009) J. W. Vardiman et al.   BLOOD